Trial intelligence / Profile preview

PK and Food Effect of Lafutidine in Healthy Chinese Subjects

NCT02658864Phase 1Completed

Start
Apr 2005
Primary completion
Jun 2005
Modality
Small Molecules
01

Overview

Phase 1, randomised, open-label trial of lafutidine in chronic gastritis (3 arms). Primary endpoints: Maximum Plasma Concentration, Area Under the Curve and 2 more. Started Apr 2005; status: completed.

02

Drugs

lafutidine
03

Conditions

chronic gastritis

Beyond the preview

Go deeper on NCT02658864.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02658864.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call